Submit an IND for AMT-260
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 May 2022
- Due
- 31 Dec 2023
- Delivered
- 5 Sep 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“plans to initiate a GLP toxicity study in non-human primates in the second half of 2022 to support an IND submission in 2023.”
What we found
Evidence strength A What the grades mean
The company successfully submitted and received FDA clearance for the IND application for AMT-260 in September 2023, meeting the 2023 deadline.
-
A uniQure N.V. 10-K filed 2024-02-28
“On September 5, 2023 we announced that the FDA had cleared the IND application for AMT-260.” ✓ confirmed on the page
Market reaction: the shares moved -18.4% against the S&P 500 over the three sessions around the disclosure (27 Feb 2024 to 1 Mar 2024). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory filing
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- AMT-260 IND submission
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-QURE-001804 · Corrections policy